Detailed Information on Publication Record
2011
Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate
HLADÍKOVÁ, Magdaléna, Anna VAŠKŮ, Pavel ŠTOURAČ, Yvonne BENEŠOVÁ, Josef BEDNAŘÍK et. al.Basic information
Original name
Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate
Authors
HLADÍKOVÁ, Magdaléna (203 Czech Republic, guarantor, belonging to the institution), Anna VAŠKŮ (203 Czech Republic, belonging to the institution), Pavel ŠTOURAČ (203 Czech Republic, belonging to the institution), Yvonne BENEŠOVÁ (203 Czech Republic, belonging to the institution) and Josef BEDNAŘÍK (203 Czech Republic, belonging to the institution)
Edition
Journal of the Neurological Sciences, Elsevier Science, 2011, 0022-510X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30211 Orthopaedics
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.353
RIV identification code
RIV/00216224:14740/11:00054011
Organization unit
Central European Institute of Technology
UT WoS
000289339900004
Keywords in English
Multiple sclerosis; Angiotensin converting enzyme; Angiotensinogen; Polymorphism; Neuroinflammation
Tags
International impact, Reviewed
Změněno: 24/3/2012 07:38, Olga Křížová
Abstract
V originále
A total of 195 patients with multiple sclerosis (MS) and 126 controls were investigated for angiotensinogen/(-6)A/G, M235T/and angiotensin converting enzyme I/D gene polymorphisms to test their association with MS susceptibility and/or disease progression using Global Multiple Sclerosis Severity Score (MSSS). We demonstrated a significant association of M235T polymorphism with MSSS. The MM homozygotes had the lowest (3.8), heterozygotes MT higher (5.2) and homozygotes TT the highest (5.4) mean MSSS values (P = 0.02). For polymorphisms (-6)A/G of ATG, only a trend was observed (P = 0.06), where the homozygotes GG carried lower MSSS values than heterozygotes and homozygotes AA. No significant association with susceptibility was observed. For ACE I/D polymorphism, neither significant differences in the genotype-phenotype study nor in the case-control study were observed.
Links
MSM0021622404, plan (intention) |
|